[Federal Register Volume 87, Number 54 (Monday, March 21, 2022)]
[Notices]
[Page 16003]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05801]



[[Page 16003]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Lead Exposure and Prevention Advisory Committee (LEPAC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Lead Exposure and Prevention 
Advisory Committee (LEPAC). This is a virtual meeting and is open to 
the public. Advance registration by April 28, 2022, is needed to 
receive the information to join the meeting. The registration link is 
provided in the addresses section below.

DATES: The meeting will be held on May 12, 2022, from 9:00 a.m. to 4:30 
p.m., EDT.

ADDRESSES: Register in advance at https://www.zoomgov.com/webinar/register/WN_JpapSgFXRKmeHVU9hW4jVQ to receive information to join the 
meeting.

FOR FURTHER INFORMATION CONTACT: Alexis Pullia, M.P.H., C.P.H., 
Committee Management Specialist, National Center for Environmental 
Health, CDC, 4770 Buford Highway, Atlanta, Georgia 30341, Telephone: 
770-488-3300; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Background: The Lead Exposure and Prevention Advisory Committee was 
established under Section 2203 of Public Law 114-322, the Water 
Infrastructure Improvements for the Nation Act; 42 U.S.C. 300j-21, 
Registry for Lead Exposure and Prevention Advisory Committee.
    Purpose: The LEPAC is charged with providing advice and guidance to 
the Secretary, Department of Health and Human Services (HHS), and the 
Director, CDC and Administrator, ATSDR, on (1) reviewing Federal 
programs and services available to individual communities exposed to 
lead; (2) reviewing current research on lead exposure to identify 
additional research needs; (3) reviewing and identifying best 
practices, or the need for best practices regarding lead screening and 
the prevention of lead poisoning; (4) identifying effective services, 
including services relating to healthcare, education, and nutrition for 
individuals and communities affected by lead exposure and lead 
poisoning, including in consultation with, as appropriate, the lead 
exposure registry as established in Section 2203(b) of Public Law 114-
322; and 5) undertaking any other review or activities that the 
Secretary determines to be appropriate.
    Matters To Be Considered: The agenda will include updates on the 
Flint Lead Registry and lead-related activities from LEPAC Members; 
information on lead exposure in Clarksburg, West Virginia; and 
discussions on the following: Infrastructure initiatives related to 
lead; lead in air, soil, and blood; navigating multiple funding streams 
at the local level; and policy approaches to improve childhood blood 
lead testing rates. Agenda items are subject to change as priorities 
dictate.

Public Participation

    Oral Public Comment: The public comment period is scheduled on May 
12, 2022, from 12:00 p.m. until 12:15 p.m., EDT. Individuals wishing to 
make a comment during the public comment period, please email your 
name, organization, and phone number by April 28, 2022, to 
[email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-05801 Filed 3-18-22; 8:45 am]
BILLING CODE 4163-18-P